Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 43 rd Annual J.P ...

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

The Japanese December Household Confidence arrived at 36.2, weaker than expectations of 36.6. Pre-Market U.S. Stock Movers Sana Biotechnology (SANA) spiked about +217% in pre-market trading after ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Offers Comprehensive Resource to Help Small Business Owners Save Money and Avoid Common Tax Pitfalls IRVINE, CA / ACCESSWIRE ...

GCash, the biggest fintech platform in the Philippines, has picked banks to work on an initial public offering that could ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Morgan Stanley likes financials, energy, real estate, and domestically-focused materials and consumer-goods companies.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

With Alonso continuing to explore free agency, it's becoming more clear what the slugger is looking for. The New York Post's Jon Heyman reports Wednesday that the gulf between the Mets and Alonso ...